The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Efficacy and safety of talquetamab, a G protein-coupled receptor family C group 5 member D x CD3 bispecific antibody, in patients with relapsed/refractory multiple myeloma (RRMM): Updated results from MonumenTAL-1.
 
Monique C. Minnema
Consulting or Advisory Role - Janssen-Cilag (Inst)
Speakers' Bureau - Celgene/Bristol-Myers Squibb (Inst); Janssen medical Affairs (Inst); Medscape (Inst)
 
Amrita Y. Krishnan
Leadership - Sutro Biopharma
Stock and Other Ownership Interests - Bristol-Myers Squibb
Consulting or Advisory Role - Bristol-Myers Squibb; GlaxoSmithKline; Janssen; Pfizer; Regeneron; Sanofi
Speakers' Bureau - Bristol-Myers Squibb; GlaxoSmithKline; Takeda
Research Funding - Janssen
 
Jesus G. Berdeja
Consulting or Advisory Role - Bluebird Bio (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); crispr therapeutics (Inst); Janssen (Inst); Kite, a Gilead company (Inst); Legend Biotech (Inst); Secura Bio (Inst); Takeda (Inst)
Research Funding - Abbvie (Inst); Acetylon Pharmaceuticals (Inst); Amgen (Inst); Bluebird Bio (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Celularity (Inst); crispr therapeutics (Inst); EMD Serono (Inst); Genentech/Roche (Inst); GlaxoSmithKline (Inst); Ichnos Sciences (Inst); Incyte (Inst); Janssen (Inst); Lilly (Inst); Novartis (Inst); poseida therapeutics (Inst); Sanofi (Inst); Takeda (Inst); Teva (Inst)
 
Albert Oriol Rocafiguera
Consulting or Advisory Role - Amgen; Celgene; GlaxoSmithKline; Janssen; Sanofi
Speakers' Bureau - Amgen; Celgene
 
Niels W.C.J. van de Donk
Honoraria - Bristol-Myers Squibb/Celgene
Consulting or Advisory Role - Amgen; Bayer; Bristol-Myers Squibb/Celgene; Janssen; Novartis; Roche; SERVIER; Takeda
Research Funding - Amgen; Cellectis; Janssen
 
Paula Rodríguez-Otero
Honoraria - Abbvie; Amgen; Celgene; GlaxoSmithKline; Janssen; Kite, a Gilead company; Oncopeptides; Pfizer; Sanofi; Takeda
Consulting or Advisory Role - BMS; GlaxoSmithKline; Janssen; Oncopeptides; Pfizer; Sanofi
 
Daniel Morillo
Honoraria - Abbvie; Janssen; Takeda
 
Maria-Victoria Mateos
Honoraria - Abbvie/Genentech; Amgen; Celgene; GlaxoSmithKline; Janssen-Cilag; Sanofi; Takeda
Consulting or Advisory Role - Abbvie; Amgen; Celgene; GlaxoSmithKline; Janssen-Cilag; Pfizer; Regeneron; Roche/Genentech; Takeda
 
Luciano J. Costa
Honoraria - Amgen; Celgene; Janssen; Karyopharm Therapeutics; Sanofi
Consulting or Advisory Role - Abbvie; Amgen; Celgene; Karyopharm Therapeutics
Speakers' Bureau - Amgen; Sanofi
Research Funding - Amgen; Janssen
 
Jo Caers
Consulting or Advisory Role - Celgene/Bristol-Myers Squibb; Janssen medical Affairs; Sanofi
Research Funding - Janssen Oncology (Inst)
Patents, Royalties, Other Intellectual Property - Patent deposition on the use of CD-38 binding nanobodies
 
Deeksha Vishwamitra
Employment - Janssen Oncology
Stock and Other Ownership Interests - Johnson & Johnson/Janssen
 
Joanne Ma
Employment - Johnson & Johnson/Janssen; Johnson & Johnson/Janssen
Stock and Other Ownership Interests - Johnson & Johnson/Janssen
 
Shiyi Yang
Employment - J&J
 
Brandi Hilder
Employment - Janssen Oncology
Stock and Other Ownership Interests - Janssen
 
Jaszianne A. Tolbert
Employment - Janssen Oncology
Stock and Other Ownership Interests - Johnson & Johnson/Janssen
Research Funding - Janssen Oncology
 
Jenna D. Goldberg
Employment - Janssen
Stock and Other Ownership Interests - Janssen
 
Ajai Chari
Consulting or Advisory Role - Abbvie; Amgen; Antengene; Bristol-Myers Squibb/Celgene; Genentech; Genzyme; GlaxoSmithKline; Janssen Oncology; Karyopharm Therapeutics; OncoPeptides; Seagen; Secura Bio; Shattuck Labs; Takeda
Research Funding - Amgen; Celgene; Janssen; Pharmacyclics; Seagen; Takeda